1. Home
  2. LPAA vs LFCR Comparison

LPAA vs LFCR Comparison

Compare LPAA & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LPAA
  • LFCR
  • Stock Information
  • Founded
  • LPAA 2024
  • LFCR 1986
  • Country
  • LPAA United States
  • LFCR United States
  • Employees
  • LPAA N/A
  • LFCR N/A
  • Industry
  • LPAA
  • LFCR Biotechnology: Pharmaceutical Preparations
  • Sector
  • LPAA
  • LFCR Health Care
  • Exchange
  • LPAA Nasdaq
  • LFCR Nasdaq
  • Market Cap
  • LPAA 299.3M
  • LFCR 288.0M
  • IPO Year
  • LPAA 2024
  • LFCR N/A
  • Fundamental
  • Price
  • LPAA $10.53
  • LFCR $6.78
  • Analyst Decision
  • LPAA
  • LFCR Buy
  • Analyst Count
  • LPAA 0
  • LFCR 4
  • Target Price
  • LPAA N/A
  • LFCR $8.00
  • AVG Volume (30 Days)
  • LPAA 10.2K
  • LFCR 211.7K
  • Earning Date
  • LPAA 01-01-0001
  • LFCR 10-03-2025
  • Dividend Yield
  • LPAA N/A
  • LFCR N/A
  • EPS Growth
  • LPAA N/A
  • LFCR N/A
  • EPS
  • LPAA 0.35
  • LFCR N/A
  • Revenue
  • LPAA N/A
  • LFCR $128,867,000.00
  • Revenue This Year
  • LPAA N/A
  • LFCR $4.71
  • Revenue Next Year
  • LPAA N/A
  • LFCR $10.98
  • P/E Ratio
  • LPAA $29.84
  • LFCR N/A
  • Revenue Growth
  • LPAA N/A
  • LFCR 0.47
  • 52 Week Low
  • LPAA $9.96
  • LFCR $4.33
  • 52 Week High
  • LPAA $10.70
  • LFCR $8.85
  • Technical
  • Relative Strength Index (RSI)
  • LPAA 69.60
  • LFCR 39.12
  • Support Level
  • LPAA $10.42
  • LFCR $6.72
  • Resistance Level
  • LPAA $10.51
  • LFCR $7.46
  • Average True Range (ATR)
  • LPAA 0.02
  • LFCR 0.41
  • MACD
  • LPAA 0.00
  • LFCR -0.07
  • Stochastic Oscillator
  • LPAA 58.82
  • LFCR 9.41

About LPAA Launch One Acquisition Corp. Class A Ordinary shares

Launch One Acquisition Corp is a blank check company.

About LFCR Lifecore Biomedical Inc.

Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.

Share on Social Networks: